111 (YI) EBT (2017 - 2025)

111 (YI) posted EBT of -$928000.0 for Q4 2025, down 357.14% sequentially from -$203000.0 in Q3 2025, and up 46.02% YoY from -$635550.6 in Q4 2024.

111 (YI) EBT (2017 - 2025) Analysis & Trends

111 has reported EBT for 9 years, with the latest figure at -$928000.0 in Q4 2025.

Quarterly EBT rose 46.02% year-over-year to -$928000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.1 million (down 10.14% YoY) and the FY2025 annual result came in at -$3.2 million, down 13.51% from the prior year.
EBT slipped to -$928000.0 in Q4 2025 per YI's latest filing, from -$203000.0 in the prior quarter.
Over five years, EBT peaked at -$203000.0 in Q3 2025 and troughed at -$28.9 million in Q4 2023.
A 5-year average of -$10.4 million and a median of -$8.8 million in 2023 frame the typical range for EBT.
The sharpest annual moves came in 2024 and 2025: EBT jumped 95.67% in 2024, then sank 262.5% in 2025.
Over 5 years, EBT stood at -$16.0 million in 2021, then grew by 5.5% to -$15.1 million in 2022, then tumbled by 91.43% to -$28.9 million in 2023, then surged by 94.05% to -$1.7 million in 2024, then soared by 46.02% to -$928000.0 in 2025.
According to Business Quant data, EBT over the past three periods registered -$928000.0, -$203000.0, and -$1.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBT (Qtr)
1	Mckesson	100.02 Bn	94.85 Bn	3.69 Bn	1.31 Bn
2	Cencora	60.88 Bn	58.06 Bn	3.61 Bn	996.39 Mn
3	Cardinal Health	54.14 Bn	49.29 Bn	2.56 Bn	554.00 Mn
4	Henry Schein	10.05 Bn	9.90 Bn	1.10 Bn	137.00 Mn
5	Akso Health	737.16 Mn	736.96 Mn	-	-
6	Edap Tms	159.12 Mn	137.58 Mn	7.34 Mn	-14.40 Mn
7	Accendra Health	100.85 Mn	93.20 Mn	263.41 Mn	-87.63 Mn
8	111	32.10 Mn	-26.65 Mn	18.18 Mn	-3.89 Mn
9	Cosmos Health	12.73 Mn	10.29 Mn	1.51 Mn	-6.09 Mn
10	VitaNova Life Sciences	11.51 Mn	9.91 Mn	264,662.00	-107,000.00

Download Data